Reduction of heart failure guideline‐directed medication during hospitalization: prevalence, risk factors, and outcomes

Reduction of heart failure guideline‐directed medication during hospitalization: prevalence, risk factors, and outcomes

Abstract Aims Optimal management of heart failure with reduced ejection fraction (HFrEF) includes titration of guideline‐directed medical therapy (GDMT) to the highest tolerated dose within the licensed range. During hospitalization, GDMT doses are often significantly altered, although it is unknown...

Full description

Bibliographic Details
Main Authors: Victoria Palin, Michael Drozd, Ellis Garland, Anam Malik, Sam Straw, Melanie McGinlay, Alexander Simms, V. Kate Gatenby, Anshuman Sengupta, Eylem Levelt, Klaus K. Witte, Mark T. Kearney, Richard M. Cubbon
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:ESC Heart Failure
Subjects:
Hospitalization
Medication
Dose
Non‐cardiovascular
Prognosis
Online Access:https://doi.org/10.1002/ehf2.14051

Internet

https://doi.org/10.1002/ehf2.14051

Similar Items